Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

140.34
+2.351.70%
Post-market: 138.89-1.4500-1.03%19:59 EDT
Volume:18.57M
Turnover:2.61B
Market Cap:56.03B
PE:-17.53
High:144.20
Open:134.10
Low:133.86
Close:137.99
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.60
T/O Rate:5.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.29
PE(LYR):-19.33

Loading ...

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.
·
Aug 16

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

TIPRANKS
·
Aug 14

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Aug 13

Stock Track | Moderna Soars Over 5% Intraday on First mRNA Flu Vaccine FDA Approval and Q2 Earnings Beat

Stock Track
·
Aug 13

Movement Alert|Moderna, Inc. Rises 5.17% in Regular Trading, First mRNA Flu Vaccine FDA Approval Combined with Q2 Earnings Beat

Market Focus
·
Aug 12

Stock Track | Moderna Soars 5% in Pre-Market as FDA Approval of First mRNA Flu Vaccine Continues to Drive Gains

Stock Track
·
Aug 10

Movement Alert|Moderna, Inc. Rises 5.15% in Pre-Market Trading, First mRNA Flu Vaccine FDA Approval Continues to Boost Shares

Market Focus
·
Aug 10

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Moderna CEO Stephane Bancel Disposes of 499,246 Shares for $9.56 Million

Reuters
·
Aug 08

Stock Track | Moderna Soars 5.28% Intraday as First mRNA Flu Vaccine Wins FDA Approval

Stock Track
·
Aug 07

Movement Alert|Moderna, Inc. Rises 5.31% in Regular Trading, First mRNA Flu Vaccine Wins FDA Approval

Market Focus
·
Aug 07

Soligenix Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 07

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End

Reuters
·
Aug 07

U.S. Stocks on the MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International

Reuters
·
Aug 07

Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva

TIPRANKS
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future

Dow Jones
·
Aug 06

Pre-Market Outlook: US Index Futures Mixed; Memory Chip Stocks Slide on SanDisk and Western Digital Guidance Miss

Stock News
·
Aug 06

Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand

Reuters
·
Aug 06